Results 151 to 160 of about 153,196 (274)

Supramolecular structures: An introduction to the JBC reviews thematic series. [PDF]

J Biol Chem
Jez JM, Peti W.
europepmc   +1 more source

Менеджмент трудоресурсного забезпечення в контексті стратегії соціально-економічного та інноваційного розвитку регіональної економіки

, 2014
The article considers the actual problem of management of labor-resource providing region's economy in line with the strategy of socio-economic and innovative development of the region, the theoretical and methodological approaches to the adequate and ...
Bugaeva, Maria, Бугайова, М. В.   +1 more
core  

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Confidence, animal spirits, and the macroeconomy in China: Based on mixed-frequency data models. [PDF]

PLoS One
Lu W, Liu Q, Li H.
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

The Kaiser Permanente Scholars Academy: A Model for Sustainable Workforce Development and Community Health. [PDF]

Nurs Adm Q
Murray T, West N.
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

The Perils of Ablative Stereotactic Radiosurgery for the Nucleus Accumbens: A Historical Perspective Urging Caution. [PDF]

Cureus
Sun B, Nuttin B, Wu H, De Salles A, Schulder M, Adler J.   +5 more
europepmc   +1 more source

Publication hyper-inflation in the field of intensive care. [PDF]

Intensive Care Med, 2023
Tsutsumi Y, Tsuchiya A, Kawahara T.
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source